Month: October 2025
-
Munich I Regional Court’s written reasons for multi-country pharma PI: out-of-district defendants can be sued, German procedures apply
The Munich I Regional Court’s headnotes are highly instructive and make the court an attractive forum for cross-border injunctions.
-
Amid transatlantic patent dispute with SAP, Celonis achieves spectacular revival of U.S. antitrust complaint (reminiscent of FTC v. Meta)
Rarely can a U.S. antitrust plaintiff revive a dismissed complaint the way Celonis just achieved against SAP. The two are embroiled in a patent dispute in the U.S. and Europe.
-
Meet Philips Principal Licensing Counsel John Sideris
“Philips’s underlying principles, which have acted like a compass for the company with regard to IP, have not changed in decades,” John Sideris, who has been at the company since 2007, told ip fray following Via LA’s Bridge Summit in San Francisco.
-
BREAKING: Via LA licensors M&K, Gensquare LLC, Tagivan II suing next Big Tech defendant Amazon in Germany over HEVC SEPs
The new suits, filed by Cohausz & Florack and Krieger Mes, target Amazon devices capable of 4K playback, including Fire TV.
-
Ericsson, Nokia, Fraunhofer reveal successful 6G-powered submission for next video codec standard: considerably higher compression, energy efficiency, scalability
The tech giants have partnered with Germany’s Fraunhofer Institute to “shape and drive” the next generation of video coding standardization, with their joint submission to the oversight bodies already positively evaluated.
-
Nokia signs new patent licensing agreement with pay-TV provider Starz
The deal marks Nokia’s sixth licensing agreement in the video technology patent space this year.
-
UPC Roundup (1 week): scope of res judicata clarified; EPO examiner criticized for negligence; injunctions and more
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our October 19, 2025 UPC Roundup.
-
UPC’s Central Division (Milan seat) declined to assess 50 non-modular invalidity attacks in detail, terminated analysis after strongest few
A leave-no-stone-unturned approach by bioMérieux to a Labrador patent has led the Milan seat of the UPC’s Central Division to clarify how to deal with an excessive number of invalidity contentions.
-
10x, Roche, Prognosys target Illumina in fresh patent infringement suits over gene sequencing
The two suits, filed in the United States District Court for the District of Delaware, involve nine patents related to single-cell genetic sequencing and spatial technologies.
-
ZTE, Samsung apparently finalizing global patent settlement as Munich court canceled today’s SEP trial on short notice
The last-minute cancelation of today’s ZTE v. Samsung SEP trial in Munich strongly suggests that a settlement has been reached in principle and the parties are now just finalizing the details.